<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36931142</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1876-035X</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of infection and public health</Title><ISOAbbreviation>J Infect Public Health</ISOAbbreviation></Journal><ArticleTitle>Prevalence and risk factor for long COVID in children and adolescents: A meta-analysis and systematic review.</ArticleTitle><Pagination><StartPage>660</StartPage><EndPage>672</EndPage><MedlinePgn>660-672</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jiph.2023.03.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1876-0341(23)00071-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Millions of COVID-19 pediatric survivors are facing the risk of long COVID after recovery from acute COVID-19. The primary objective of this study was to systematically review the available literature and determine the pooled prevalence of, and risk factors for long COVID among the pediatric survivors.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Studies that assessed the prevalence of, or risk factors associated with long COVID among pediatric COVID-19 survivors were systematically searched in PubMed, Embase, and Cochrane Library up to December 11th, 2022. Random effects model was performed to estimate the pooled prevalence of long COVID among pediatric COVID-19 patients. Subgroup analyses and meta-regression on the estimated prevalence of long COVID were performed by stratification with follow-up duration, mean age, sex ratio, percentage of multisystem inflammatory syndrome, hospitalization rate at baseline, and percentage of severe illness.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Based on 40 studies with 12,424 individuals, the pooled prevalence of any long COVID was 23.36 % ([95 % CI 15.27-32.53]). The generalized symptom (19.57 %, [95 % CI 9.85-31.52]) was reported most commonly, followed by respiratory (14.76 %, [95 % CI 7.22-24.27]), neurologic (13.51 %, [95 % CI 6.52-22.40]), and psychiatric (12.30 %, [95% CI 5.38-21.37]). Dyspnea (22.75 %, [95% CI 9.38-39.54]), fatigue (20.22 %, [95% CI 9.19-34.09]), and headache (15.88 %, [95 % CI 6.85-27.57]) were most widely reported specific symptoms. The prevalence of any symptom during 3-6, 6-12, and&gt;&#xa0;12 months were 26.41 % ([95 % CI 14.33-40.59]), 20.64 % ([95 % CI 17.06-24.46]), and 14.89 % ([95 % CI 6.09-26.51]), respectively. Individuals with aged over ten years, multisystem inflammatory syndrome, or had severe clinical symptoms exhibited higher prevalence of long COVID in multi-systems. Factors such as older age, female, poor physical or mental health, or had severe infection or more symptoms were more likely to have long COVID in pediatric survivors.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Nearly one quarter of pediatric survivors suffered multisystem long COVID, even at 1 year after infection. Ongoing monitoring, comprehensive prevention and intervention is warranted for pediatric survivors, especially for individuals with high risk factors.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Yong-Bo</ForeName><Initials>YB</Initials><AffiliationInfo><Affiliation>Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University, Beijing, China; Peking-Tsinghua Centre for Life Sciences and PKU-IDG/McGovern Institute for Brain Research, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Na</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing, China; School of Public Health, Peking University, Beijing, China; Beijing Friendship Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Kai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Shan-Shan</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Ying-Bo</ForeName><Initials>YB</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Xinxiang Medical University, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Nan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Xinxiang Medical University, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Xinxiang Medical University, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>An-Yi</ForeName><Initials>AY</Initials><AffiliationInfo><Affiliation>Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kondratiuk</LastName><ForeName>Alexandra L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>NIHR Health Protection Research Unit in Respiratory Infections, National Heart and Lung Institute, Imperial College, London W2 1NY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Pei-Pei</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Department of Neurology, Taiyuan Central Hospital of Shanxi Medical University, Taiyuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Pain Medicine Center, Peking University Third Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yue</LastName><ForeName>Jing-Li</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Xiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Le</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lalvani</LastName><ForeName>Ajit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>NIHR Health Protection Research Unit in Respiratory Infections, National Heart and Lung Institute, Imperial College, London W2 1NY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bao</LastName><ForeName>Yan-Ping</ForeName><Initials>YP</Initials><AffiliationInfo><Affiliation>National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing, China; School of Public Health, Peking University, Beijing, China. Electronic address: baoyp@bjmu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University, Beijing, China; Peking-Tsinghua Centre for Life Sciences and PKU-IDG/McGovern Institute for Brain Research, Peking University, Beijing, China; National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing, China. Electronic address: linlu@bjmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Infect Public Health</MedlineTA><NlmUniqueID>101487384</NlmUniqueID><ISSNLinking>1876-0341</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000705967">pediatric multisystem inflammatory disease, COVID-19 related</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Children</Keyword><Keyword MajorTopicYN="N">Inflammatory multisystem syndrome</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword></KeywordList><CoiStatement>Conflict of interest The authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>17</Day><Hour>19</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36931142</ArticleId><ArticleId IdType="pmc">PMC9990879</ArticleId><ArticleId IdType="doi">10.1016/j.jiph.2023.03.005</ArticleId><ArticleId IdType="pii">S1876-0341(23)00071-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. &#x3008;https://www.who.int/emergencies/diseases/novel-coronavirus-2019&#x3009;. Accessed at January 5th, 2023.</Citation></Reference><Reference><Citation>Marshall M. The lasting misery of coronavirus long-haulers. Nature. 2020;585(7825):339&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pubmed">32929257</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeting the challenge of long COVID. Nat Med 2020; 26(12): 1803.</Citation><ArticleIdList><ArticleId IdType="pubmed">33288947</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102&#x2013;e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y.M., Shi L., Jiang Z.D., et al. The phenotype and prediction of long-term physical, mental and cognitive COVID-19 sequelae 20 months after recovery, a community-based cohort study in China. Mol Psychiatry. 2023;23:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9869317</ArticleId><ArticleId IdType="pubmed">36690792</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T., Hittle M., Goodman S.N. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021;4(5)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng N., Zhao Y.M., Yan W., et al. A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action. Mol Psychiatry. 2023;28(1):423&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9168643</ArticleId><ArticleId IdType="pubmed">35668159</ArticleId></ArticleIdList></Reference><Reference><Citation>Wulf Hanson S., Abbafati C., Aerts J.G., et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328(16):1604&#x2013;1615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2021</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L., Ni S.Y., Yan W., et al. Mental and neurological disorders and risk of COVID-19 susceptibility, illness severity and mortality: a systematic review, meta-analysis and call for action. EClinicalMedicine. 2021;40</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8424080</ArticleId><ArticleId IdType="pubmed">34514362</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J.E., Asfour A., Sewell T.B., et al. Neurological issues in children with COVID-19. Neurosci Lett. 2021;743</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7831718</ArticleId><ArticleId IdType="pubmed">33352286</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhuiyan M.U., Stiboy E., Hassan M.Z., et al. Epidemiology of COVID-19 infection in young children under five years: a systematic review and meta-analysis. Vaccine. 2021;39(4):667&#x2013;677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833125</ArticleId><ArticleId IdType="pubmed">33342635</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID and kids: more research is urgently needed. Nature 2022; 602(7896): 183.</Citation><ArticleIdList><ArticleId IdType="pubmed">35136225</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Nemati M., Nemati H. 'Long COVID': Symptom persistence in children hospitalised for COVID-19. J Paediatr Child Health. 2022;58(10):1836&#x2013;1840.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9349535</ArticleId><ArticleId IdType="pubmed">35851732</ArticleId></ArticleIdList></Reference><Reference><Citation>Penner J., Abdel-Mannan O., Grant K., et al. 6-month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: a retrospective cohort study. Lancet Child Adolesc Health. 2021;5(7):473&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pubmed">34043958</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T., Pinto Pereira S.M., Shafran R., et al. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study. Lancet Child Adolesc Health. 2022;6(4):230&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8820961</ArticleId><ArticleId IdType="pubmed">35143770</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker E., Bamford A., Kenny J., et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. Jama. 2020;324(3):259&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7281356</ArticleId><ArticleId IdType="pubmed">32511692</ArticleId></ArticleIdList></Reference><Reference><Citation>Funk A.L., Kuppermann N., Florin T.A., et al. Post-COVID-19 conditions among children 90 days after SARS-CoV-2 infection. JAMA Netw Open. 2022;5(7)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9308058</ArticleId><ArticleId IdType="pubmed">35867061</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov I.M., Spiridonova E., Bobkova P., et al. Risk factors for long covid in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study. Eur Respir J. 2022;59(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Messiah S.E., Xie L., Mathew M.S., et al. Comparison of long-term complications of COVID-19 illness among a diverse sample of children by MIS-C status. Int J Environ Res Public Health. 2022;19(20)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9603408</ArticleId><ArticleId IdType="pubmed">36293968</ArticleId></ArticleIdList></Reference><Reference><Citation>Behnood S.A., Shafran R., Bennett S.D., et al. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: a meta-analysis of controlled and uncontrolled studies. J Infect. 2022;84(2):158&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8604800</ArticleId><ArticleId IdType="pubmed">34813820</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Ayuzo Del Valle N.C., et al. Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep. 2022;12(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9226045</ArticleId><ArticleId IdType="pubmed">35739136</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup D.F., Berlin J.A., Morton S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283(15):2008&#x2013;2012.</Citation><ArticleIdList><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med. 2009;6(7)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashkenazi-Hoffnung L., Shmueli E., Ehrlich S., et al. Long COVID in children: observations from a designated pediatric clinic. Pediatr Infect Dis J. 2021;40(12):e509&#x2013;e511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8575093</ArticleId><ArticleId IdType="pubmed">34371507</ArticleId></ArticleIdList></Reference><Reference><Citation>Brackel C.L.H., Lap C.R., Buddingh E.P., et al. Pediatric long-COVID: an overlooked phenomenon? Pediatr Pulmonol. 2021;56(8):2495&#x2013;2502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8242715</ArticleId><ArticleId IdType="pubmed">34102037</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Pujol F.E., Munblit D., Pata D., McFarland S., Simpson F.K. Clinical characteristics, activity levels and mental health problems in children with long coronavirus disease: a survey of 510 children. Future Microbiol. 2022;17(8):577&#x2013;588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9248023</ArticleId><ArticleId IdType="pubmed">35360923</ArticleId></ArticleIdList></Reference><Reference><Citation>Erol N., Alpinar A., Erol C., Sari E., Alkan K. Intriguing new faces of Covid-19: persisting clinical symptoms and cardiac effects in children. Cardiol Young. 2022;32(7):1085&#x2013;1091.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8438511</ArticleId><ArticleId IdType="pubmed">34407902</ArticleId></ArticleIdList></Reference><Reference><Citation>Knoke L., Schlegtendal A., Maier C., Eitner L., L&#xfc;cke T., Brinkmann F. Pulmonary function and long-term respiratory symptoms in children and adolescents after COVID-19. Front Pediatr. 2022;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9081758</ArticleId><ArticleId IdType="pubmed">35547532</ArticleId></ArticleIdList></Reference><Reference><Citation>Matteudi T., Luciani L., Fabre A., et al. Clinical characteristics of paediatric COVID-19 patients followed for up to 13 months. Acta Paediatr. 2021;110(12):3331&#x2013;3333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444774</ArticleId><ArticleId IdType="pubmed">34403523</ArticleId></ArticleIdList></Reference><Reference><Citation>Radtke T., Ulyte A., Puhan M.A., Kriemler S. Long-term symptoms after SARS-CoV-2 infection in children and adolescents. JAMA. 2021;326(9):869&#x2013;871.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8283661</ArticleId><ArticleId IdType="pubmed">34264266</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusetsky Y., Meytel I., Mokoyan Z., Fisenko A., Babayan A., Malyavina U. Smell status in children infected with SARS-CoV-2. Laryngoscope. 2021;131(8):E2475&#x2013;e80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013292</ArticleId><ArticleId IdType="pubmed">33443298</ArticleId></ArticleIdList></Reference><Reference><Citation>Say D., Crawford N., McNab S., Wurzel D., Steer A., Tosif S. Post-acute COVID-19 outcomes in children with mild and asymptomatic disease. Lancet Child Adolesc Health. 2021;5(6):e22&#x2013;e23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8057863</ArticleId><ArticleId IdType="pubmed">33891880</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterky E., Olsson-&#xc5;kefeldt S., Hertting O., et al. Persistent symptoms in Swedish children after hospitalisation due to COVID-19. Acta Paediatr. 2021;110(9):2578&#x2013;2580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444740</ArticleId><ArticleId IdType="pubmed">34157167</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang A., Shi L., Yan W., et al. Mental Health in Children in the Context of COVID-19: Focus on Discharged Children. Front Psychiatry. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8631929</ArticleId><ArticleId IdType="pubmed">34858232</ArticleId></ArticleIdList></Reference><Reference><Citation>Ak&#xe7;ay E., &#xc7;&#xf6;p E., Din&#xe7; G.S., et al. Loneliness, internalizing symptoms, and inflammatory markers in adolescent COVID-19 survivors. Child: care, Health Dev. 2022;48(6):1112&#x2013;1121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9537962</ArticleId><ArticleId IdType="pubmed">35946414</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartoszek M., Ma&#x142;ek &#x141;.A, Barczuk-Fal&#x119;cka M., Brzewski M. Cardiac magnetic resonance follow-up of children after pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 with initial cardiac involvement. J Magn Reson Imaging. 2022;55(3):883&#x2013;891.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8426796</ArticleId><ArticleId IdType="pubmed">34327751</ArticleId></ArticleIdList></Reference><Reference><Citation>Blankenburg J., Wekenborg M.K., Reichert J., et al. Comparison of mental health outcomes in seropositive and seronegative adolescents during the COVID19 pandemic. Sci Rep. 2022;12(1):2246.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8831534</ArticleId><ArticleId IdType="pubmed">35145161</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B., Mohn K.G., Brokstad K.A., et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021;27(9):1607&#x2013;1613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Bode S.F.N., Haendly M., Fabricius D., et al. Pulmonary function and persistent clinical symptoms in children and their parents 12 months after mild SARS-CoV-2 infection. Front Pediatr. 2022;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9279894</ArticleId><ArticleId IdType="pubmed">35844730</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Munblit D., Pazukhina E., et al. Post-COVID condition in adults and children living in the same household in Italy: a prospective cohort study using the ISARIC global follow-up protocol. Front Pediatr. 2022;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9070551</ArticleId><ArticleId IdType="pubmed">35529336</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Pazukhina E., Gentili C., et al. The prevalence, characteristics and risk factors of persistent symptoms in non-hospitalized and hospitalized children with SARS-CoV-2 infection followed-up for up to 12 months: a prospective, cohort study in Rome, Italy. J Clin Med. 2022;11:22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9692851</ArticleId><ArticleId IdType="pubmed">36431250</ArticleId></ArticleIdList></Reference><Reference><Citation>Denina M., Pruccoli G., Scolfaro C., et al. Sequelae of COVID-19 in hospitalized children: a 4-months follow-up. Pediatr Infect Dis J. 2020;39(12):e458&#x2013;e459.</Citation><ArticleIdList><ArticleId IdType="pubmed">33003103</ArticleId></ArticleIdList></Reference><Reference><Citation>Dole&#x17e;alov&#xe1; K., Tukov&#xe1; J., Pohunek P. The respiratory consequences of COVID-19 lasted for a median of 4 months in a cohort of children aged 2&#x2013;18 years of age. Acta Paediatr Int J Paediatr. 2022;111(6):1201&#x2013;1206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9111221</ArticleId><ArticleId IdType="pubmed">35175667</ArticleId></ArticleIdList></Reference><Reference><Citation>Enner S., Shah Y.D., Ali A., et al. Patients diagnosed with multisystem inflammatory syndrome in children have persistent neurologic, sleep, and psychiatric symptoms after hospitalization. J Child Neurol. 2022;37(5):426&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pubmed">35072534</ArticleId></ArticleIdList></Reference><Reference><Citation>Esmaeilzadeh H., Sanaei Dashti A., Mortazavi N., Fatemian H., Vali M. Persistent cough and asthma-like symptoms post COVID-19 hospitalization in children. BMC Infect Dis. 2022;22(1):244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8917254</ArticleId><ArticleId IdType="pubmed">35279094</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink T.T., Marques H.H.S., Gualano B., et al. Persistent symptoms and decreased health-related quality of life after symptomatic pediatric COVID-19: a prospective study in a Latin American tertiary hospital. Clinics. 2021;76</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8595593</ArticleId><ArticleId IdType="pubmed">34852145</ArticleId></ArticleIdList></Reference><Reference><Citation>Gennaro L., Valentini P., Sorrentino S., et al. Extended coagulation profile of children with Long Covid: a prospective study. Sci Rep. 2022;12(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9626616</ArticleId><ArticleId IdType="pubmed">36319840</ArticleId></ArticleIdList></Reference><Reference><Citation>Guido C.A., Lucidi F., Midulla F., et al. Neurological and psychological effects of long COVID in a young population: a cross-sectional study. Front Neurol. 2022;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9428748</ArticleId><ArticleId IdType="pubmed">36062008</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiss R., Tan L., Schmidt S., et al. Pulmonary dysfunction after pediatric COVID-19. Radiology. 2022</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9513839</ArticleId><ArticleId IdType="pubmed">36125379</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe9;ndez-Echevarr&#xed;a A., Sainz T., Falces-Romero I., et al. Long-term persistence of anti-sars-cov-2 antibodies in a pediatric population. Pathogens. 2021;10:6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8226775</ArticleId><ArticleId IdType="pubmed">34199852</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell E.C., Romano A., Capone C.A., et al. Multisystem inflammatory syndrome in children: salient echocardiogram findings in the acute phase and longitudinal follow-up. Prog Pediatr Cardiol. 2022;66</Citation></Reference><Reference><Citation>Namazova-Baranova L., Karkashadze G., Zelenkova I., et al. A non-randomized comparative study of olfactory and gustatory functions in children who recovered from COVID-19 (1-year follow-up) Front Pediatr. 2022;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9505991</ArticleId><ArticleId IdType="pubmed">36160805</ArticleId></ArticleIdList></Reference><Reference><Citation>Nugawela M.D., Stephenson T., Shafran R., et al. Predictive model for long COVID in children 3 months after a SARS-CoV-2 PCR test. BMC Med. 2022;20:1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9708506</ArticleId><ArticleId IdType="pubmed">36447237</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;zt&#xfc;rk G.K., Beken B., Do&#x11f;an S., Akar H.H. Pulmonary function tests in the follow-up of children with COVID-19. Eur J Pediatr. 2022;181(7):2839&#x2013;2847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9072762</ArticleId><ArticleId IdType="pubmed">35522314</ArticleId></ArticleIdList></Reference><Reference><Citation>Palacios S., Krivchenia K., Eisner M., et al. Long-term pulmonary sequelae in adolescents post-SARS-CoV-2 infection. Pediatr Pulmonol. 2022;57(10):2455&#x2013;2463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9349789</ArticleId><ArticleId IdType="pubmed">35775163</ArticleId></ArticleIdList></Reference><Reference><Citation>Patnaik S., Jain M.K., Ahmed S., et al. Short-term outcomes in children recovered from multisystem inflammatory syndrome associated with SARS-CoV-2 infection. Rheumatol Int. 2021;41(11):1957&#x2013;1962.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8278175</ArticleId><ArticleId IdType="pubmed">34259880</ArticleId></ArticleIdList></Reference><Reference><Citation>Pazukhina E., Andreeva M., Spiridonova E., et al. Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12&#x2009;months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID) BMC Med. 2022;20(1):244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9257572</ArticleId><ArticleId IdType="pubmed">35794549</ArticleId></ArticleIdList></Reference><Reference><Citation>Sezer M., &#xc7;elikel E., Tekin Z.E., et al. Multisystem inflammatory syndrome in children: clinical presentation, management, and short- and long-term outcomes. Clin Rheumatol. 2022;41(12):3807&#x2013;3816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9411826</ArticleId><ArticleId IdType="pubmed">36018446</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirico D., Basso A., Sabatino J., et al. Evolution of echocardiographic and cardiac magnetic resonance imaging abnormalities during follow-up in patients with multisystem inflammatory syndrome in children. Eur Heart J Cardiovasc Imaging. 2022;23(8):1066&#x2013;1074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9384104</ArticleId><ArticleId IdType="pubmed">35639926</ArticleId></ArticleIdList></Reference><Reference><Citation>Penner J., Abdel-Mannan O., Grant K., et al. 6-month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: a retrospective cohort study. Lancet Child Adolesc Health. 2021;5(7):473&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pubmed">34043958</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao Y., Sun Y., Meng S., Shi J., Lu L. 2019-nCoV epidemic: address mental health care to empower society. Lancet. 2020;395(10224):e37&#x2013;e38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7133594</ArticleId><ArticleId IdType="pubmed">32043982</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi L., Lu Z.A., Que J.Y., et al. Prevalence of and risk factors associated with mental health symptoms among the general population in China during the coronavirus disease 2019 pandemic. JAMA Netw Open. 2020;3(7)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7330717</ArticleId><ArticleId IdType="pubmed">32609353</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Shi L., Que J., et al. The impact of quarantine on mental health status among general population in China during the COVID-19 pandemic. Mol Psychiatry. 2021;26(9):4813&#x2013;4822.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7821451</ArticleId><ArticleId IdType="pubmed">33483692</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y.B., Shi L., Lu Z.A., et al. Mental health status of late-middle-aged adults in China during the coronavirus disease 2019 pandemic. Front Public Health. 2021;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8187778</ArticleId><ArticleId IdType="pubmed">34123986</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan K., Zheng Y.B., Wang Y.J., et al. A systematic review and meta-analysis on prevalence of and risk factors associated with depression, anxiety and insomnia in infectious diseases, including COVID-19: a call to action. Mol Psychiatry. 2022;27(8):3214&#x2013;3222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9168354</ArticleId><ArticleId IdType="pubmed">35668158</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J.J., Bao Y., Huang X., Shi J., Lu L. Mental health considerations for children quarantined because of COVID-19. Lancet Child Adolesc Health. 2020;4(5):347&#x2013;349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7118598</ArticleId><ArticleId IdType="pubmed">32224303</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan K., Gong Y.M., Liu L., et al. Prevalence of posttraumatic stress disorder after infectious disease pandemics in the twenty-first century, including COVID-19: a meta-analysis and systematic review. Mol Psychiatry. 2021;26(9):4982&#x2013;4998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7861006</ArticleId><ArticleId IdType="pubmed">33542468</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Espuny Pujol F., Munblit D., McFarland S., Simpson F. Clinical characteristics, activity levels and mental health problems in children with Long COVID: a survey of 510 children. Preprint 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9248023</ArticleId><ArticleId IdType="pubmed">35360923</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldstein L.R., Rose E.B., Horwitz S.M., et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383(4):334&#x2013;346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7346765</ArticleId><ArticleId IdType="pubmed">32598831</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov I.M., Spiridonova E., Bobkova P., et al. Risk factors for long covid in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Behnood S.A., Shafran R., Bennett S.D., et al. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: a meta-analysis of controlled and uncontrolled studies. J Infect. 2021</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8604800</ArticleId><ArticleId IdType="pubmed">34813820</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>